Inventor · disambiguated record
Joshua Sk Bell
Also filed as: BELL JOSHUA S K · BELL JOSHUA SK
6 granted patents·9 pending applications·41 citations·filing 2020–2024
80Inventor score
Top patents by PatentIndex Score
15 records- 0192US11043283B1Systems and methods for automating RNA expression calls in a cancer prediction pipelineTEMPUS LABS INC·Filed 2020·Granted Jun 22, 2021·12 cites·54 claims
- 0290US11527323B2Systems and methods for multi-label cancer classificationTEMPUS LABS INC·Filed 2020·Granted Dec 13, 2022·15 cites·8 claims
- 0390US10975445B2Integrated machine-learning framework to estimate homologous recombination deficiencyTEMPUS LABS INC·Filed 2020·Granted Apr 13, 2021·12 cites·31 claims
- 0485US11164655B2Systems and methods for predicting homologous recombination deficiency status of a specimenTEMPUS LABS INC·Filed 2020·Granted Nov 2, 2021·2 cites·26 claims
- 0575US2025364135A1Systems and methods for multi-label cancer classificationTEMPUS AI INC·Filed 2024·Application pending·0 cites
- 0669US2023114581A1Systems and methods for predicting homologous recombination deficiency status of a specimenTEMPUS LABS INC·Filed 2022·Application pending·0 cites
- 0768US11367004B2Real-world evidence of diagnostic testing and treatment patterns in U.S. breast cancer patients with implications for treatment biomarkers from RNA-sequencing dataTEMPUS LABS INC·Filed 2020·Granted Jun 21, 2022·0 cites·29 claims
- 0868US2022351805A1Systems and methods for detecting cellular pathway dysregulation in cancer specimensTEMPUS LABS INC·Filed 2022·Application pending·0 cites
- 0967US2022028482A1Systems and methods for predicting homologous recombination deficiency status of a specimenTEMPUS LABS INC·Filed 2021·Application pending·0 cites
- 1066US2021248479A1Real-World Evidence of Diagnostic Testing and Treatment Patterns in U.S. Breast Cancer Patients with Implications for Treatment Biomarkers from RNA-Sequencing DataTEMPUS LABS INC·Filed 2021·Application pending·0 cites
- 1165US2021272649A1Systems and methods for automating rna expression calls in a cancer prediction pipelineTEMPUS LABS INC·Filed 2021·Application pending·0 cites
- 1265US2023187070A1Systems and methods for multi-label cancer classificationTEMPUS LABS INC·Filed 2022·Application pending·0 cites
- 1363US11367508B2Systems and methods for detecting cellular pathway dysregulation in cancer specimensTEMPUS LABS INC·Filed 2020·Granted Jun 21, 2022·0 cites·35 claims
- 1462US2021142904A1Systems and methods for multi-label cancer classificationTEMPUS LABS INC·Filed 2021·Application pending·0 cites
- 1555US2023144221A1Methods and systems for detecting alternative splicing in sequencing dataTEMPUS LABS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joshua Sk Bell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →